Posted in | News | Business

Praxair to Acquire Linde's Mexican Industrial and Medical Gases Business

Praxair Inc. announced today that it has entered into a definitive agreement with The Linde Group to acquire Linde's industrial and medical gases business in Mexico. Linde's Mexican business operates under the name of AGA S.A. de C.V. Terms of the transaction were not disclosed. The transaction excludes the Mexican assets of the BOC Group, which Linde acquired as part of their worldwide acquisition of BOC.

The agreement has been approved by Mexico's Federal Competition Commission and the transaction is expected to close in a few weeks.

The sale of Linde's Mexican business is part of a mutual agreement between Praxair and Linde under which Linde acquired the Turkey-based industrial gases producer Karbogaz A. S. in July, 2006. Karbogaz was formerly a joint venture company between Praxair and Ismail Aytemiz of Istanbul, Turkey.

AGA S.A. de C.V. was acquired by the Linde Group in 1999 as part of its acquisition of Swedish gases producer AGA A.B. The business operates throughout Mexico, generating sales of approximately $75 million in fiscal 2006.

"The acquisition of AGA S.A. de C.V. will increase our presence in the metropolitan area of Mexico City and place Praxair Mexico in a position to maintain its strong sales growth in the years ahead," said Eduardo Menezes, managing director, Praxair Mexico.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.